HY209 Gel

· Shaperon

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HY209 Gel, covering 2020-10-19 to 2022-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon) [Phase 2]